Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)

BME:ROVI Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	724.2	763.75	829.51	817.7	648.68	419.96
Revenue Growth (YoY)	-9.39%	-7.93%	1.44%	26.06%	54.46%	10.14%
Cost of Revenue	272.29	296.04	346.17	305.27	268.84	182.83
Gross Profit	451.91	467.71	483.34	512.43	379.84	237.14
Selling, General & Admin	165.24	158.26	147.02	129.99	103.36	84.83
Other Operating Expenses	106.44	102.73	92.52	105.84	74.96	57.8
Operating Expenses	301.33	289.01	263.87	258.69	199.68	162.22
Operating Income	150.58	178.71	219.47	253.74	180.15	74.92
Interest Expense	-2.82	-2.35	-0.95	-0.85	-0.91	-1.07
Interest & Investment Income	0.03	0.03	0.01	0.01	0.07	0
Earnings From Equity Investments	-0.05	-0.14	-0.13	0.2	0.18	-0.03
Currency Exchange Gain (Loss)	-0.08	0.3	-0.09	-0.82	-0.18	0.04
Other Non Operating Income (Expenses)	10.42	1.15	2.09	3.93	3.4	0.12
EBT Excluding Unusual Items	158.07	177.69	220.41	256.21	182.72	73.98
Gain (Loss) on Sale of Investments	-	-	-	1.76	-	-
Asset Writedown	-0.56	-	-	-0	-0.1	-0.06
Other Unusual Items	-	-	-	-	-	-1.34
Pretax Income	157.52	177.69	220.41	257.97	182.63	72.58
Income Tax Expense	36.41	40.81	50.11	58.3	29.55	11.52
Earnings From Continuing Operations	121.1	136.88	170.3	199.67	153.08	61.06
Minority Interest in Earnings	0.05	0.01	0.04	0	-	-
Net Income	121.15	136.88	170.34	199.67	153.08	61.06
Net Income to Common	121.15	136.88	170.34	199.67	153.08	61.06
Net Income Growth	-26.57%	-19.64%	-14.69%	30.44%	150.71%	55.47%
Shares Outstanding (Basic)	51	51	53	53	55	55
Shares Outstanding (Diluted)	51	51	53	53	55	55
Shares Change (YoY)	-	-3.73%	-0.51%	-3.50%	0.03%	0.37%
EPS (Basic)	2.37	2.67	3.20	3.73	2.76	1.10
EPS (Diluted)	2.37	2.67	3.20	3.73	2.76	1.10
EPS Growth	-	-16.53%	-14.25%	35.31%	150.36%	54.89%
Free Cash Flow	111.03	79.16	59.45	186.88	109.22	7.54
Free Cash Flow Per Share	2.17	1.55	1.12	3.50	1.97	0.14
Dividend Per Share	0.935	0.935	1.104	1.294	0.956	0.381
Dividend Growth	-	-15.28%	-14.69%	35.39%	150.68%	117.70%
Gross Margin	62.40%	61.24%	58.27%	62.67%	58.55%	56.47%
Operating Margin	20.79%	23.40%	26.46%	31.03%	27.77%	17.84%
Profit Margin	16.73%	17.92%	20.53%	24.42%	23.60%	14.54%
Free Cash Flow Margin	15.33%	10.37%	7.17%	22.86%	16.84%	1.80%
EBITDA	173.12	199.62	238.02	271.33	196.56	89.61
EBITDA Margin	23.91%	26.14%	28.69%	33.18%	30.30%	21.34%
D&A For EBITDA	22.54	20.91	18.54	17.59	16.41	14.69
EBIT	150.58	178.71	219.47	253.74	180.15	74.92
EBIT Margin	20.79%	23.40%	26.46%	31.03%	27.77%	17.84%
Effective Tax Rate	23.12%	22.97%	22.73%	22.60%	16.18%	15.88%
Advertising Expenses	-	21.74	21.75	19.99	12.71	11.41

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.